IDEXX Laboratories Inc (IDXX) stock
IDXXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 19/3036% above fair value
$698.47+8.23 (+1.19%)
Close on Nov 18, 2026Market cap $55.03BP/E 49.1Yield –
IDEXX Laboratories price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
IDEXX Laboratories's price to book ratio was 34.4× on Nov 11, 2026, against 38.6× a year earlier. Over the last 5 years it ranged from 21.0× to 83.8×, with a median of 33.2×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 34.4× | −0.3 |
| 2025 | Dec 31, 2025 | 34.7× | +13.7 |
| 2024 | Dec 31, 2024 | 21.0× | −14.6 |
| 2023 | Dec 29, 2023 | 35.5× | −35.6 |
| 2022 | Dec 30, 2022 | 71.1× | −2.9 |
| 2021 | Dec 31, 2021 | 74.1× | −22.7 |
| 2020 | Dec 31, 2020 | 96.8× | −14.0 |
| 2019 | Dec 31, 2019 | 110.8× | −92.5 |
| 2017 | Jan 31, 2017 | 203.3× | +8.4 |
| 2016 | Dec 30, 2016 | 194.9× | −17.2 |
| 2015 | Jul 31, 2015 | 212.1× | +178.6 |
| 2014 | Dec 31, 2014 | 33.5× | +22.6 |
| 2013 | Dec 31, 2013 | 10.9× | +2.4 |
| 2012 | Dec 31, 2012 | 8.5× | +0.8 |
| 2011 | Dec 30, 2011 | 7.7× | +0.1 |
| 2010 | Dec 31, 2010 | 7.6× | – |
See a number that looks wrong?